Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Clopidogrel Bisulfate Tablets

Approval Number

国药准字HC20220002

Company

中国台湾培力药品工业股份有限公司

Registration Date

July 7, 2022

Drug Information

Generic Name

硫酸氢氯吡格雷片

Dosage Form

片剂

Strength

75mg（按C₁₆H₁₆ClNO₂S计）

Drug Type

化学药品

Registration Date

July 7, 2022

Expiry Date

July 6, 2027

Company Information

Applicant Company

Company Name

中国台湾培力药品工业股份有限公司

Company Address

中国台湾台中市西屯区工业区六路11号

Manufacturing Company

Company Name

pei li pharmaceutical industrial co.,ltd.

Company Address

中国台湾台中市西屯区工业区六路11号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy